232 related articles for article (PubMed ID: 25204258)
1. Pharmacoepidemiological study of drug-drug interactions in onco-hematological pediatric patients.
Fernández de Palencia Espinosa MA; Díaz Carrasco MS; Fuster Soler JL; Ruíz Merino G; De la Rubia Nieto MA; Espuny Miró A
Int J Clin Pharm; 2014 Dec; 36(6):1160-9. PubMed ID: 25204258
[TBL] [Abstract][Full Text] [Related]
2. Potential drug-drug interactions in oncological adult inpatients at a Spanish hospital: epidemiology and risk factors.
Fernández de Palencia Espinosa MÁ; Díaz Carrasco MS; Alonso Romero JL; de la Rubia Nieto A; Espuny Miró A
Int J Clin Pharm; 2015 Dec; 37(6):1021-7. PubMed ID: 26391788
[TBL] [Abstract][Full Text] [Related]
3. Potential drug-drug interactions in hospitalised haematological patients.
Fernández de Palencia Espinosa MÁ; Díaz Carrasco MS; Sánchez Salinas A; de la Rubia Nieto A; Miró AE
J Oncol Pharm Pract; 2017 Sep; 23(6):443-453. PubMed ID: 27511216
[TBL] [Abstract][Full Text] [Related]
4. Drug-drug interactions in pediatric oncology patients.
Balk TE; van der Sijs IH; van Gelder T; Janssen JJB; van der Sluis IM; van Leeuwen RWF; Engels FK
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28205376
[TBL] [Abstract][Full Text] [Related]
5. Real clinical impact of drug-drug interactions of immunosuppressants in transplant patients.
Gago-Sánchez AI; Font P; Cárdenas M; Aumente MD; Del Prado JR; Calleja MÁ
Pharmacol Res Perspect; 2021 Dec; 9(6):e00892. PubMed ID: 34755493
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.
Ramos GV; Guaraldo L; Japiassú AM; Bozza FA
J Clin Pharm Ther; 2015 Feb; 40(1):63-7. PubMed ID: 25329640
[TBL] [Abstract][Full Text] [Related]
7. Identification of adverse drug reactions in geriatric inpatients using a computerised drug database.
Egger T; Dormann H; Ahne G; Runge U; Neubert A; Criegee-Rieck M; Gassmann KG; Brune K
Drugs Aging; 2003; 20(10):769-76. PubMed ID: 12875612
[TBL] [Abstract][Full Text] [Related]
8. Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis.
Dechanont S; Maphanta S; Butthum B; Kongkaew C
Pharmacoepidemiol Drug Saf; 2014 May; 23(5):489-97. PubMed ID: 24616171
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of drug-drug interactions in hospitalized dermatology patients.
Ganeva M; Gancheva T; Troeva J; Kiriyak N; Hristakieva E
Adv Clin Exp Med; 2013; 22(4):555-63. PubMed ID: 23986216
[TBL] [Abstract][Full Text] [Related]
10. Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy.
Leone R; Magro L; Moretti U; Cutroneo P; Moschini M; Motola D; Tuccori M; Conforti A
Drug Saf; 2010 Aug; 33(8):667-75. PubMed ID: 20635825
[TBL] [Abstract][Full Text] [Related]
11. A 6-year retrospective study of adverse drug reactions due to drug-drug interactions between nervous system drugs.
Shi QP; He XD; Yu ML; Zhu JX; Liu Y; Ding F; Sang R; Jiang XD; Zhang SQ
Int J Clin Pharmacol Ther; 2014 May; 52(5):392-401. PubMed ID: 24691061
[TBL] [Abstract][Full Text] [Related]
12. Detection and analysis of drug-drug interactions among hospitalized cardiac patients in the Mohammed V Military Teaching Hospital in Morocco.
Fettah H; Moutaouakkil Y; Sefrioui MR; Moukafih B; Bousliman Y; Bennana A; Lamsaouri J; Makram S; Cherrah Y
Pan Afr Med J; 2018; 29():225. PubMed ID: 30100979
[TBL] [Abstract][Full Text] [Related]
13. Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: a multicenter study.
Khan Q; Ismail M; Khan S
BMC Pharmacol Toxicol; 2017 Dec; 18(1):75. PubMed ID: 29191244
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of clinically manifested drug interactions in hospitalized patients: A systematic review and meta-analysis.
Gonzaga de Andrade Santos TN; Mendonça da Cruz Macieira G; Cardoso Sodré Alves BM; Onozato T; Cunha Cardoso G; Ferreira Nascimento MT; Saquete Martins-Filho PR; Pereira de Lyra D; Oliveira Filho AD
PLoS One; 2020; 15(7):e0235353. PubMed ID: 32609783
[TBL] [Abstract][Full Text] [Related]
15. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
Toivo TM; Mikkola JA; Laine K; Airaksinen M
Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
[TBL] [Abstract][Full Text] [Related]
16. Comparison of potential drug-drug interactions with metabolic syndrome medications detected by two databases.
Suriyapakorn B; Chairat P; Boonyoprakarn S; Rojanarattanangkul P; Pisetcheep W; Hunsakunachai N; Vivithanaporn P; Wongwiwatthananukit S; Khemawoot P
PLoS One; 2019; 14(11):e0225239. PubMed ID: 31725785
[TBL] [Abstract][Full Text] [Related]
17. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study.
Lin CF; Wang CY; Bai CH
Drugs Aging; 2011 Mar; 28(3):219-25. PubMed ID: 21250763
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital.
Ramasubbu SK; Mahato SK; Agnihotri A; Pasricha RK; Nath UK; Das B
Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of potential drug-drug interactions in bone marrow transplant patients.
Guastaldi RB; Reis AM; Figueras A; Secoli SR
Int J Clin Pharm; 2011 Dec; 33(6):1002-9. PubMed ID: 21993569
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of QT interval prolonging drug-drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study.
Khan Q; Ismail M; Haider I; Khan F
Int J Clin Pharm; 2017 Dec; 39(6):1256-1264. PubMed ID: 28895028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
